Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 1461Neoplasms 987Colorectal Neoplasms 823Carcinoma, Non-Small-Cell Lung 714Carcinoma, Hepatocellular 680Stomach Neoplasms 644Lung Neoplasms 575Prostatic Neoplasms 539Pancreatic Neoplasms 451Rectal Neoplasms 334Uterine Cervical Neoplasms 303Neoplasm Metastasis 294Colonic Neoplasms 291Ovarian Neoplasms 281Recurrence 278Esophageal Neoplasms 273Leukemia, Myeloid, Acute 251Head and Neck Neoplasms 239Multiple Myeloma 231Brain Neoplasms 204Polycystic Ovary Syndrome 198Nasopharyngeal Carcinoma 197Melanoma 195Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Urinary Bladder Neoplasms 189Lymphoma 177Liver Neoplasms 175Endometrial Neoplasms 158Motor Activity 142Lymphoma, Large B-Cell, Diffuse 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × OTHER × Pseudomonas Infections × Clear all
NCT05975151 2023-09-21

Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Qilu Hospital of Shandong University

Phase 2 Unknown
63 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Pseudomonas Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡